The pharmaceutical industry and the internet: Are drug company funded depression websites biased?

References

• Angell, M. (2004). The truth about drug companies: How they deceive us and what to do about it. New York: Random House.
   Google Scholar
• Angermeyer, M., Dietrich, S. (2006). Public beliefs about and attitudes towards people with mental illness: A review of population studies. Acta Psychiatrica Scandinavica, 113, 163–179.
   PubMed Web of Science ®Google Scholar
• Antonuccio, D.O., Burns, D.D., Danton, W.G. (2002). Antidepressants: A triumph of marketing over science. Prevention and Treatment, 5, 25.
   Google Scholar
• Antonuccio, D.O., Danton, W.G., DeNelsky, G.Y. (1995). Psychotherapy versus medication for depression: Challenging the conventional wisdom with data. Professional Psychology: Research and Practice, 50, 450–452.
   Google Scholar
• Antonuccio, D.O., Thomas, M., Danton, W.G. (1997). A cost effective analysis of cognitive behavioural therapy and fluoxetine (prozac) in the treatment of depression. Behavioural Therapy, 28, 187–210.
   Web of Science ®Google Scholar
• Bekelman, J.E., Li, Y., Gross, P.C. (2003). Scope and impact of financial conflict of interest in biomedical research. A systematic review. Journal of American Medical Associaton, 289, 454–465.
   PubMed Web of Science ®Google Scholar
• Choudhry, N.K., Stelfox, H.T., Detsky, A.S. (2002). Relations between authors of clinical practise guidelines and the pharmaceutical industry. The Journal of the American Medical Association, 287, 614.
   Web of Science ®Google Scholar
• Cosgrove, L., Krimsky, S., Vijayaraghavan, M., Schneider, L. (2006). Financial ties between DSM-IV panel members and the pharmaceutical industry. Psychotherapy and Psychosomatics, 75, 154–160.
   PubMed Web of Science ®Google Scholar
• Findlayson, G., Mullner, R. (2005). Direct to consumer advertising of prescription drugs: Help or hindrance to the public' s health. Journal of Consumer Marketing, 22, 429–431.
   Google Scholar
• Healy, D., Thase, M.E. (2003). Is academic psychiatry for sale. British Journal of Psychiatry, 182, 388–391.
   PubMed Web of Science ®Google Scholar
• Hollon, S.D., Thase, M.E., Markowitz, J.C. (2002). Treatment and prevention of depression. Psychological Science in the Public Interest, 3, 39–77.
   PubMed Web of Science ®Google Scholar
• Hunter, D. (2007). Antidepressants and the pharmaceutical companies: Corporate responsibilities. Broomall, PA: Mason Crest Publishers.
   Google Scholar
• Kirsch, I., Deacon, B., Huedo-Medina, T., Scoboria, A., Moore, T., Johnson, B. (2008). Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLOS Medicine, 5, 260–268.
   Web of Science ®Google Scholar
• Law, J. (2006). Big pharma: How the world's biggest drug companies control illness. London: Constable and Robinson.
   Google Scholar
• Leo, J., Lacasse, J. (2007). The media and the chemical imbalance theory of depression. Society, 45, 35–45.
   Web of Science ®Google Scholar
• Read, J. (2008). Schizophrenia, drug companies and the internet. Social Science & Medicine, 66, 99–109.
   PubMed Web of Science ®Google Scholar
• Read, J., Haslam, N. (2004). Public opinion: Bad things happen and can drive you crazy. In: J. Read, L. Mosher, R. Bentall (Eds.), Models of madness: Psychological, social and biological approaches to schizophrenia ( pp. 133–145). Hove, UK: Brunner-Routledge.
   Google Scholar
• Schowalter, J. (2008). How to manage conflicts of interest with industry. International Review of Psychiatry 20, 127–133.
   Google Scholar
• Sharfstein, S. (2005). Big Pharma and American psychiatry: The good, the bad, and the ugly. Psychiatric News, 40, 3.
   Google Scholar
• Shooter, M.S. (2005). Dancing with the devil? A personal view of psychiatry's relationship with the pharmaceutical industry. Psychiatric Bulletin, 29, 81–83.
   Google Scholar
• Tungaraza, T., Poole, R. (2007). Influence of drug company authorship and sponsorship on drug outcomes. British Journal of Psychiatry, 191, 82–83.
   PubMed Web of Science ®Google Scholar
• Wazana, A. (2000). Physicians and the pharmaceutical industry, is a gift ever just a gift. Journal of the American Medical Association, 283, 373–380.
   PubMed Web of Science ®Google Scholar
• Weber, L. (2006). Profits before people?: Ethical standards and the marketing of prescription drugs. Bloomington: Indiana University Press.
   Google Scholar
• Ziegler, M.G., Lew, P., Singer, B.C. (1995). The accuracy of drug information from pharmaceutical sales representatives. Journal of the American Medical Association, 273, 1296–1298.
   PubMed Web of Science ®Google Scholar